Sales rise 25.14% to Rs 300.44 crore
Net profit of Caplin Point Laboratories rose 29.93% to Rs 70.85 crore in the quarter ended June 2021 as against Rs 54.53 crore during the previous quarter ended June 2020. Sales rose 25.14% to Rs 300.44 crore in the quarter ended June 2021 as against Rs 240.08 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales300.44240.08 25 OPM %30.8229.82 -PBDT101.5577.58 31 PBT89.5268.62 30 NP70.8554.53 30Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
